Esperling; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Esperling; Peter.The latest application filed is for "18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter".

Company Profile

0.10.6

Esperling; Peter - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter Grant 8,445,469 - Bohlmann , et al. May 21, 2	2013-05-21
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents Grant 7,504,410 - Bryant , et al. March 17, 2	2009-03-17
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, As Well As Pharmaceutical Preparations That Contain The Latter App 20090029953 - Bohlmann; Rolf ; et al.	2009-01-29
18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter App 20060252737 - Bohlmann; Rolf ; et al.	2006-11-09
18-nor steroids as selectively active estrogens App 20050282791 - Hillisch, Alexander ; et al.	2005-12-22
18 Norsteroids as selectively active estrogens Grant 6,958,327 - Hillisch , et al. October 25, 2	2005-10-25
Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds Grant 6,916,921 - Blume , et al. July 12, 2	2005-07-12
Fertilization of aged oocytes App 20040224878 - Cukurcam, Suna ; et al.	2004-11-11
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents App 20040186118 - Bryant, Judi ; et al.	2004-09-23
Process for the production of 4,4-dimethyl-5.alpha.-cholesta-8,14,24-trien-3.beta.-01 and intermediate products in process (I) Grant 6,683,197 - Blume , et al. January 27, 2	2004-01-27
Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds App 20020188143 - Blume, Thorsten ; et al.	2002-12-12
Chiral phenyldihydrofuranones as PDE-IV inhibitors Grant 6,011,060 - Laurent , et al. January 4, 2	2000-01-04
Agent for transdermal administration that contains gestodene esters Grant 5,858,394 - Lipp , et al. January 12, 1	1999-01-12
7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolactones, process for their production, and pharmaceutical preparations containing same Grant 4,559,331 - Nickisch , et al. December 17, 1	1985-12-17
Corticoid 21-sulfopropionates and the salts thereof, a process for the production thereof and pharmaceutical preparations thereof Grant 4,296,109 - Laurent , et al. October 20, 1	1981-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.